23125948224_07e0c4e1d5_o.jpg

Featured Products

Pediatric dolutegravir 10mg dispersible, scored tablets (pDTG)

Building on the 2020 World AIDS Day announcement on pediatric dolutegravir (10mg) dispersible, scored tablets (pDTG), CHAI is pleased to share a set of resources to support national decision-making and implementation of this optimal product.

6036147744_fa732aefac_o.jpg

Darunavir/ritonavir (400/50mg) fixed-dose combination (DRV/r)

Darunavir (DRV) is a best in class protease inhibitor commonly used in high-income markets, and has recently been prequalified by the WHO as a fixed-dose-combination with ritonavir (RTV) at a price of US $17.50/pack (EXW) for use in second-line in low- and middle-income countries. CHAI is pleased to share a set of resources to support national decision-making and implementation of this optimal product.

HepC_Rwanda_McNab-02603.jpg